The Enterion capsule is quickly becoming big pharma's new best
friend as the technology helps drug companies assess the
feasibility of oral modified release formulations.
Hungarian pharma Gedeon Richter has announced plans to combine with
Polish firm Polpharma to create a major presence in Central Eastern
Europe (CEE) through a share deal worth HUF231bn ($1.3bn).
Swiss firm Novartis today announced that it has contacted
regulators regarding the safety of the 100mg dose of its recently
approved Type II diabetes drug, Galvus (vildagliptin).
GlaxoSmithKline (GSK) and Fabre-Kramer Pharmaceuticals (FKP) were
dealt a blow last week as their potential first in class,
once-daily antidepressant treatment received another thumbs down
from US regulators.
Despite Genentech's recent decision to push out the cut-off date to
ban the sale of cancer drug Avastin (bevacizumab) to compounding
pharmacies in the US to restrict off-label use, ophthalmologists
still find the firm's...
GPC Biotech has met another obstacle in its path towards
satraplatin approval after the German company announced
disappointing and unexpected results in its Phase III trial.
SCOLR Pharma has initiated the first of three pivotal trials to
evaluate its extended release ibuprofen tablet, with hopes that it
will be the first and only 12-hour formulation on the market.
A nifty spray-on solution could make all the difference for men
plagued with the problem of climaxing too soon, as the product
makes its final thrust in clinical development.
Bayer Schering Pharma this week announced that it has scrapped
plans to introduce a double-dose version of its top-selling
multiple sclerosis (MS) drug Betaferon (interferon beta-1b) by the
end of the year following disappointing...
GlaxoSmithKline (GSK) has been swift in implementing its plant
cuts, already announcing the first sites to be axed mere hours
after revealing its restructuring plans.
The race is on between cervical cancer vaccines Gardasil and
Cervarix as they begin to battle it out to win a more than £100m a
year supply contract with the UK Department of Health.
Indian generics specialist Wockhardt is continuing its drive to
strengthen its foothold in the US market, snapping up US firm
Morton Grove Pharmaceuticals.
King Pharmaceuticals last week announced that it would be cutting
20 per cent of its workforce after the US Court of Appeals reversed
a previous court ruling and invalidated a patent covering the
firm's blood pressure drug, Altace...
Roche heard early this morning that the European Commission (EC)
has decided to reinstate the marketing authorisation for the
company's HIV drug, Viracept (nelfinavir), but countries outside
the EU have yet to make a final decision.
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.
Drug formulation and delivery specialist Orexo has decided it has
had enough of improving established drugs and wants to develop its
own, so has bought speciality pharma firm Biolipox.
Several big drug-makers are voluntarily recalling some of their
cough and cold products for under-two-year-olds in the US as a
precautionary measure against overdosing on the drugs.
Two manufacturers launched their docetaxel products at CPhI last
week, each trying to stake their claim in the market in
anticipation of patent expiries on Sanofi-Aventis' Taxotere
(docetaxel) towards the end of the year.
Dutch chemicals and excipients distributor Univar has hooked up
with US manufacturer Innophos to provide the EU pharmaceutical
market with its entire portfolio of excipients, helping to fill the
gap left by the departure of Rhodia...
UK-based TeraView has had its tablet imaging technology backed by
the US Food and Drug Administration (FDA), following a study by the
regulatory agency.
The European Fine Chemicals Group (EFCG) has called for stricter
regulation of pharmaceutical excipients in a bid to prevent
substandard and potentially dangerous products ending up in
medicinal drugs.
SAFC has announced its plans to build a new high potency
conjugation suite at its Missouri manufacturing plant in order to
target pharma clients developing novel anti-cancer drug conjugates.
The US Food and Drug Administration (FDA) has been called into
question again after the release of a damning report, this time
suggesting the agency is inadequate in its safety monitoring of
clinical trials.
Discovery Laboratories could see the end of its struggle to launch
its Surfaxin (lucinactant) drug on the US market as it has finally
resolved the manufacturing issues that have plagued the product for
months.
An extended release formulation of an asthma treatment recently
recommended by the National Asthma Education and Prevention Program
has been launched on the US market.
Following the recent news that pharma heavyweight Pfizer has also
been struck by contamination of its HIV drug Viracept (nelfinavir),
in-PharmaTechnologist.com spoke to the US Food and Drug
Administration (FDA) to find out how far...
SolVin is to expand its polyvinylidene chloride (PVDC) latex
manufacturing site in Tavaux, France, in a bid to meet growing
demand for the packaging material.
